āĻšā§āĻŽINO âĸ BMV
add
Inovio Pharmaceuticals Inc
ā§¨ā§Ŧ.ā§Ļā§Ļ$
ā§Ž āĻā§āĻ˛, ā§Š:ā§Ļā§Ļ:ā§§ā§Ļ PM GMT -ā§Ŧ · MXN · BMV · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§¨ā§Ģ.ā§Ļā§Ļ$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§¨ā§Ŧ.ā§Ļā§Ļ$ - ā§¨ā§Ž.ā§Ļā§Ļ$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§¨ā§Ģ.ā§Ļā§Ļ$ - ā§¨ā§¨ā§Ē.ā§Šā§Ļ$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§Ŧ.ā§Žā§ŠÂ āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§§ā§¯ā§¨.ā§Ļā§Ļ
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
-
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
NASDAQ
āĻāĻŦāĻ°ā§ āĻ°ā§ā§āĻā§
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (USD) | āĻŽāĻžāĻ°ā§āĻ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ŧā§Ģ.ā§Šā§Ē āĻšāĻž | â |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§¯ā§Ļ.ā§¨ā§Ģ āĻ˛āĻž | -ā§§ā§Ē.ā§Ŧā§Š% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§§.ā§¯ā§Â āĻā§ | ā§Šā§Ģ.ā§Šā§Ŧ% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | -ā§Šā§Ļ.ā§§ā§Ē āĻšāĻž | â |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | -ā§Ļ.ā§Ģā§§ | ā§Ŧā§§.ā§Ļā§% |
EBITDA | -ā§¨.ā§Ēā§Â āĻā§ | ā§¨ā§Ļ.ā§Ģā§Ē% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | â | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻŽāĻžāĻ°ā§āĻ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§Ŧ.ā§Žā§Ē āĻā§ | -ā§Šā§Ģ.ā§¨ā§% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Ž.ā§ā§ŠÂ āĻā§ | -ā§Šā§¨.ā§Ēā§§% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Š.ā§Ŧā§Ļ āĻā§ | ā§Š.ā§Žā§¯% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ģ.ā§§ā§ŠÂ āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§Š.ā§Ŧā§Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§§ā§.ā§Žā§Ŧ | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Ŧā§¨.ā§Ēā§Ž% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | -ā§Žā§.ā§Ŧā§Ŧ% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (USD) | āĻŽāĻžāĻ°ā§āĻ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§§.ā§¯ā§Â āĻā§ | ā§Šā§Ģ.ā§Šā§Ŧ% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | -ā§¨.ā§Ŧā§¯Â āĻā§ | ā§Ŧ.ā§Ģā§Ŧ% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§Ģā§§.ā§ā§Ģ āĻšāĻž | -ā§§ā§Ļā§Ļ.ā§§ā§§% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§§ā§Ļ.ā§¨ā§ŽÂ āĻ˛āĻž | ā§§ā§Ļā§¯.ā§Ļā§Ģ% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | -ā§¨.ā§Ģā§¯Â āĻā§ | -ā§Ģā§Žā§¯.ā§Ēā§% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | -ā§¨.ā§§ā§Ģ āĻā§ | -ā§¨ā§Ŧ.ā§ā§Ģ% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§§ā§Šā§Ē
